1 Erratum to: Int J Hematol DOI 10.1007/s12185-010-0624-7

There are errors in Table 2. The numbers and the percentages for grades 3 and 4 adverse events are incorrectly aligned. The correct version of the table appears on the following page.

Table 2 Lenalidomide-related adverse events with NCI-CTCAE grade 3 or 4 (n = 15)